Acquired blue blindness is a feature of:
The main acquired causes I remember are related to certain medications. For example, chloroquine and hydroxychloroquine, which are used for malaria and autoimmune diseases, can cause retinal toxicity. They specifically target the macula and can lead to a blue-yellow color vision deficit. Another possible cause might be Wilson's disease, but that's more related to copper accumulation and Kayser-Fleischer rings. Or, maybe some other metabolic disorders? Wait, but the question is about acquired, not congenital.
Looking at the options, if one of them is chloroquine or hydroxychloroquine, that's the answer. Let me double-check: chloroquine toxicity leads to retinopathy with a characteristic "bull's eye" maculopathy and affects blue cones. So acquired blue blindness is a feature of chloroquine toxicity. The other options might include things like vitamin A deficiency, but that's more about night blindness. Or maybe lead poisoning, but that's associated with optic neuropathy. So the correct answer must be chloroquine or hydroxychloroquine.
Now, structuring the explanation. The core concept is that acquired blue blindness is due to specific drug toxicities affecting the blue cones. The correct answer is chloroquine/hydroxychloroquine. The wrong options would include other drugs or conditions that don't cause blue blindness. The clinical pearl is to remember that these drugs cause retinal toxicity with blue-yellow deficit. Need to make sure each section is concise and fits the character limit.
**Core Concept**
Acquired blue blindness refers to **blue cone dysfunction** due to **drug-induced retinal toxicity**, specifically affecting **short-wavelength-sensitive cones** (S-cones) in the macula. The most common cause is **chloroquine/hydroxychloroquine** toxicity, which leads to **bull's eye maculopathy**.
**Why the Correct Answer is Right**
Chloroquine and hydroxychloroquine accumulate in the retinal pigment epithelium, causing **macular degeneration** and **blue-yellow color vision loss**. These drugs bind to phospholipids in the retina, disrupting **lysosomal function** and inducing apoptosis of photoreceptor cells. The blue cone deficit is due to their higher metabolic vulnerability in the **macula**, where S-cones are densely packed.
**Why Each Wrong Option is Incorrect**
**Option A:** Vitamin A deficiency causes **night blindness** and **rod dysfunction**, not blue cone loss.
**Option B:** Wilsonβs disease leads to **copper deposition** in the cornea (Kayser-Fleischer rings) and **optic neuropathy**, not blue blindness.
**Option C:** Lead poisoning causes **dose-dependent optic neuropathy** with **central scotomas**, not selective blue cone loss.
**Clinical Pearl / High-Yield Fact**
Remember the **"chloroquine eye"**: Patients on long-term chloroquine/hydroxychloroquine should undergo **annual ophthalmologic screening** for maculopathy. Early